CEwire2026

The Largest Virtual Optometric Conference:
75 COPE Approved Credits
4 Live Weekend Events Online
1 Low Price
Featuring ALL NEW LECTURES for 2026!

LIVE Online:
January 31 & February 1
April 11 & 12
June 6 & 7
September 19 & 20

.. and ON DEMAND through December 1, 2026.

NEW: Meet your ENTIRE 8-Hour DEA Opioid Requirement!
NEW: Meet your ENTIRE NJ Orals Requirement!
NEW: Meet your ENTIRE CA 10-hour Glaucoma Requirement!
REGISTER NOW VIEW COURSE LIST

Your $229.00 $199 Early Bird All-Access Season Pass gives you access to all 75 Credits, Live Events, and On Demand Content!

Pay ONE PRICE to access:
  • ALL four live events and all on demand content!
  • Interactive/Synchronous Lectures including Real-Time Chat Text with Speakers
  • The Private CEwire2026 Discussion Forum, where attendees can securely and privately interact with speakers and other conference goers before, during and after the live events and discuss each talk
  • Exclusive Vendor Discounts
  • On Demand Lectures through December 1st, 2026

... and don't forget to watch the CEwire2026 Livestream Interview Show which runs during the live events, and features eye care industry leaders, lectures, and other special guests at the event!
REGISTER NOW LEARN MORE

About CEwire2026

Join us for the largest online CE event in optometry and see why over 20,000 ODs across the world have chosen to participate over the past decade!

Earn up to 75 COPE-approved CE credits from leading eye care experts with all-new lectures, without leaving home.

Use your conference pass to Watch LIVE online these dates:

January 31 & February 1, 2026
April 11-12, 2026
June 6-7, 2026
September 19-20, 2026


... OR watch ON DEMAND at your own pace and on your own schedule through December 1, 2026.

Register to receive exclusive discounts from leading vendors, and tune in to the CEwire2026 Livestream, where we'll chat with optometric thought leaders and eye care industry executives.

75 Hours of COPE-Approved CE: Watch LIVE or ON DEMAND!

Your registration to CEwire2026 gives you access to the lectures when they are given LIVE online.

Come to as many or as few live events as you'd like: your single conference pass gives you access to ALL the live events.

Each event features all 75 credits, so if you miss one, you can easily catch what you missed at the next live event.

Can't make it live? No problem!

Each time we do a live performance, the lectures are recorded and placed & online for you to view on demand through December 1, 2026.

Watch each archived course as many times as you like. Pause, rewind, or even watch on your phone in between patients.
REGISTER NOW

The CEwire2026 Private Forum: 24-7 Interactivity

All registrants will receive immediate access to the CEwire2026 Private Forum, where attendees and speakers can interact with each other round-the-clock. The posts in the forum provide an ongoing conversation about each lecture, throughout the year and beyond.

The forum provides you with a private and secure space where you can:
  • Ask questions before, during, and after the event
  • Interact with & get to know your fellow attendees
  • Peruse vendors discounts, and discuss their products and services with experts from each company
The forum acts as a permanent repository that you can always return to in the future -- even months or years after the conference has concluded!

No other conference gives you this sort of long-term access to information.
REGISTER NOW

CEwire2026 Livestream!

As in prior years, during the live weekends we will broadcast from CEwire HQ.

CEwire staff will give participants the latest updates on the conference in real time, including current discounts being offered at the show, and interviews with leaders in eye care.

Come join the fun!

REGISTER NOW

Taking CE Has Never Been Easier

Receiving your COPE credits is incredibly simple:

1. Register for CEwire2026 (and if it is your first time with us, remember to give us your ARBO OE Tracker # when you register, so we have it on file.)

2. Login and watch a live performance online! You can interact with the speakers via text chat at the live shows!

...OR you can watch lectures on demand, starting the day after the conclusion of the first live show, February 2, 2026 through December 1, 2026

3. If watching on one of the "LIVE" days, no quiz is required to gain credits. Simply watch an entire course, and it will be added to your transcript as a "Virtual Synchronous" credit. If watching on demand, complete a short quiz after each hour of class (take the quizzes as many times as you need to in order to pass). When you complete an on demand class, it is credited by ARBO as an "Asynchronous" credit.

4. We transmit your credits to ARBO automatically, using your ARBO OE Tracker number that you gave when you registered.

We also provide you with digital certificates after you complete each course, which are permanently archived in the ODwire.org Transcript Center should you need to look them up or download them in the future.

CEwire2026 Course List

REGISTER HERE

Course Title Hours Sync ID Async ID speaker names keywords category
GEN Z DECODED: HOW TO SUCCEED WITH GEN Z IN YOUR PRACTICE
Kayla Ashlee

Bridge the generational gap holding back your success. Doctors are completely missing the mark when communicating, motivating, working with, or selling to Gen Z. Learn what they respond to, how to build a stronger team, and a captivating optical experience for Gen Z to grow your practice.

Course Objectives:
1. Identify the mindset & values of Gen Z
2. Structure a motivating workplace for this and all generations
3. Learn how Gen Z shops to make your optical more appealing
4. Attract Gen Z patients to purchase in your optical
5. Bridge the generational gap that is holding back your success
2 PENDING PENDING Ashlee practice management, Gen Z, communication, optical PM
INHERITED RETINAL DISEASES: CHALLENGES IN DIAGNOSIS AND BREAKTHROUGHS IN TREATMENT
Roya Attar, OD, MBA, DHA, FAAO

This presentation reviews the challenges of diagnosing inherited retinal diseases (IRDs), addressing genetic heterogeneity and phenotypic variability. Attendees will learn how to implement genetic testing and other strategies to enhance diagnostic accuracy. Current breakthroughs in treatments and therapies, including gene-specific treatments and clinical trial advancements will also be discussed.

1 PENDING PENDING Attar diabetes,retinopathy TD
ILLUMINATING PRESBYOPIA — THE LATEST IN CONTACT LENS AND PHARMACEUTICAL INNOVATIONS
Melissa Barnett, OD, FAAO, FSLS, FBCLA

Discover the impact of untreated presbyopia and explore today's most exciting solutions—from advanced contact lens designs to newly emerging presbyopia correcting drops. Explore mechanisms of action, clinical evidence, and real-world strategies for treating presbyopia and expanding its potential applications.

1 PENDING PENDING Barnett presbyopia,pharma TD
THE SNEAKY VERTICALS: ANALYZING HEAD TILTS AND OCULAR MISALIGNMENTS FOLLOWING A TBI
Shirley Blanc, OD FNORA

Traumatic brain injury (TBI) can result in a complex combination of visual, cervical, and vestibular impacts that can result in binocular vision disorders and abnormal postural compensations. This course will cover the neurological basis for vertical and torsional ocular misalignments due to trauma, clinical presentations, and differential diagnosis.

1 PENDING PENDING Blanc TBI, binocular,binocularity FV
BEYOND ARTIFICIAL TEARS: BIOLOGIC THERAPIES SHAPING THE FUTURE OF DRY EYE CARE
Shelby Brogdon, OD

Biologic therapies are transforming ocular surface disease care by targeting inflammation, neurotrophic dysfunction, and epithelial repair. This course reviews current and emerging biologic options, mechanisms, evidence, and practical integration strategies to help clinicians confidently incorporate regenerative treatments into modern dry eye management.
1 PENDING PENDING Brogdon pharmacology,biologic,biologic therapy,dry eye,osd PH
SURGICAL CORRECTION OF PRESBYOPIA
Kristen Brown, OD, FAAO, Dipl CCLRT

This course reviews modern surgical strategies for presbyopia correction following cataract extraction, including multifocal, EDOF, trifocal, accommodating, and monovision IOLs. Emphasis is placed on lens selection, toric correction, patient candidacy, and perioperative co-management to optimize refractive outcomes and reduce postoperative spectacle dependence.
1 PENDING PENDING Brown Presbyopia, preop PO
MODERN TECHNOLOGY - LEVERAGING IT TO DIAGNOSE GLAUCOMA
Mile Brujic, OD, FAAO

This course explores how modern imaging, functional testing, and artificial intelligence tools enhance glaucoma diagnosis. Clinicians will learn to integrate multimodal data for early detection, accurate progression monitoring, and personalized care—moving beyond traditional methods to a technology-driven, proactive approach that improves diagnostic precision and long-term patient outcomes.
1 PENDING PENDING Brujic glaucoma, GLC GL
OCULAR FINDINGS ARE THE MISSING PUZZLE PIECE TO SYSTEMIC DISEASE
Mile Brujic, OD, FAAO

This course explores how anterior segment findings reveal early signs of systemic disease. By recognizing corneal, conjunctival, scleral, and iris changes, clinicians can identify metabolic, autoimmune, infectious, and vascular disorders before systemic symptoms appear, strengthening their role in comprehensive, interdisciplinary patient care.
1 PENDING PENDING Brujic systemic disease SD
4 PEDIATRIC NEURO OPTOMETRIC PRESENTATIONS WE CANNOT AFFORD TO MISS
Lorcan Butler, BSc (Hons), MCOptom

Although niche presentations, these 4 pediatric neuro-optometric presentations can often be sight threatening and life-threatening. The main concern is that practitioners often assume that the pediatric presentations will have the same signs & symptoms as their adult cohort presentations. This course will highlight the key differences in presentation and management of these conditions in the pediatric population.
1 PENDING PENDING Butler pediatric,neuro NO
SWOLLEN OPTIC NERVES – BUT WHICH ONE IS IT? USING THE GOLDILOCKS PRINCIPLE
Lorcan Butler, BSc (Hons), MCOptom

Swollen Optic Nerves presentation in primary care practice can be extremely challenging. Causes can be both sight-threatening and life threatening so differential diagnosis is a must. Thankfully there does tend to be quite specific age, gender, symptoms framework we can rely on. Using Goldilocks Principle of "too big", "too small" and "just right" we will be teaching delegates that by process of elimination and underpinning our existing knowledge of non-glaucomatous optic neuropathies we can rule out certain mimickers and concentrate on getting the diagnosis "just right".
1 PENDING PENDING Butler neuro NO
PRESCRIBING OPIOIDS IN 2026
Benjamin P. Casella, OD

Narcotics have an established place in place in primary eye care. Their addictive potential and relatively high risk of adverse effects means that special judiciousness should be practice with their prescription. This course will update the clinician regarding contemporary prescribing considerations as well as drug diversion and patient counseling.
2 PENDING PENDING Casella opioids,narcotics,DEA,pain PH
TRACING THE ORIGINS OF VERTICAL HETEROPHORIA (VH) AND MICROPRISM: THE SCIENCE, HISTORY AND CLINICAL BREAKTHROUGHS
Mark Rosner, MD

Explore the origins, clinical challenges, and breakthroughs in Vertical Heterophoria/Binocular Vision Dysfunction. This course traces historical foundations, Dr. Debby Feinberg's pioneering clinical discoveries, and key published and unpublished research, providing a comprehensive understanding of diagnosis, physiology, symptomatology, and treatment effectiveness using microprism and sound reduction devices.
1 PENDING PENDING Rosner vertical heterophoria,microprism,binocular vision FV
DIABETES UPDATE 2026
A. Paul Chous, MA, OD, FAAO

This course will consider breaking developments in the diagnosis and management of diabetes and associated ocular disease. Findings that impact optometric and systemic care will be presented.

Learning Objectives:
1. This course will consider some of the most important advances in diabetes care of the last year, with emphasis on systemic management and new treatment options for diabetic eye disease
2. Attendees will be presented with common misconceptions about diabetes and diabetic retinopathy
3. Attendees will be able to describe the role of weight loss and physical activity for diabetes prevention and remission, including use of GLP-1 analogs and increased pace
1 PENDING PENDING Chous diabetes, diabetic retinopathy, pharmacology, oral SD
EXERCISE FOR THE PREVENTION OF EYE DISEASE AND RELATED SYSTEMIC DISEASES
A. Paul Chous, MA, OD, FAAO

This course will examine the benefits of exercise for the prevention and mitigation of multiple eye diseases and systemic conditions related to these. Specific recommendations based on evidence will be presented for diabetes/DR, AMD, glaucoma, OSD and more (1 hour)

Learning Objectives:
1. Attendees will be able to describe international guidelines for physical activity based on MET units and examples of low, moderate and vigorous intensity exercise
2. Attendees will be able to explain to patients the evidence base for exercise in the prevention and management of common eye diseases like diabetic retinopathy, AMD, POAG, OSD and more
3. Attendees will be able to enumerate the biological mechanisms underlying the benefits of exercise for both the prevention and improvement of common eye diseases and systemic conditions linked to eye disease
1 PENDING PENDING Chous exercise, systemic disease SD
MIGS, MIGS and MORE MIGS: What should an optometrist know?
Pinakin Davey, OD, PhD, FAAO

This foundational course covers the minimally invasive glaucoma surgery (MIGS) FDA approved devices and some that are close to approval. This course covers the basics of considerations of MIGS, anatomical consideration, efficacy and controlled clinical trials that compared the devices.

At the end of this course the participants will be able to understand and recollect:
1) Anatomical and physiological considerations when recommending minimally invasive glaucoma surgery
2) Minimally invasive glaucoma surgery devices and its target IOP drainage
3) Efficacy and risks involved in the MIGS
4) Comparison of MIGS devices and randomized controlled trials of MIGS
5) Eye examination consideration of various MIGS and in Cypass that is withdrawn from the market but patients may still have the implant
1 PENDING PENDING Davey glaucoma, glc GL
HEADACHES: DISTINGUISHING THE BENIGN FROM THE MORE SERIOUS
Mark Friedberg, MD

This course will teach the history, examination and testing to perform when someone complains of headache. It will teach how to recognize migraine, cluster, tension, and some rarer forms of headache. It will highlight the red flags that suggest a more serious problem is lingering. Treatment will be discussed.
2 PENDING PENDING Friedberg headaches NO
BEYOND THE SURFACE: THE OPTOMETRIST'S GUIDE TO THE CORNEA
Susan Gromacki, MS, OD, FAAO, FSLS

The cornea is a fascinating tissue, and without its transparency, vision is compromised. This lecture will review the anatomy and physiology of the cornea, detailing its five distinct layers. Then the lecture will explain the most common diagnoses which can compromise health of the cornea, including inflammation, infection, dystrophies, and ectasia. Lastly it will present the most up-to-date treatment methods for these corneal abnormalities, including pharmaceuticals, contact lens technology, and surgery.
2 PENDING PENDING Gromacki cornea TD
ANGLE CLOSURE GLAUCOMA: AN OPTOMETRIST'S GUIDE
Mitchel J. Ibach, OD, FAAO

This lecture provides an in-depth exploration of acute glaucomas, including acute angle-closure glaucoma, secondary acute glaucomas such as Posner-Schlossman syndrome, iris bombe, hyphema, post-surgical, and drug-induced glaucomas. It covers pathophysiology, clinical presentation, diagnosis, and comprehensive management strategies, emphasizing the importance of prompt intervention and post-operative care.
1 PENDING PENDING Ibach glaucoma,angle closure GL
"I'VE DIAGNOSED OPEN-ANGLE GLAUCOMA, NOW WHAT?" A REVIEW OF FIRST-LINE GLAUCOMA TREATMENTS
Mitchel J. Ibach, OD, FAAO

This course will provide optometrists with a comprehensive understanding of first line glaucoma treatment options, including topical medications, selective laser trabeculoplasty, and emerging drug delivery systems. Attendees will compare mechanisms of action, clinical effectiveness, side effect profiles, and patient quality of life implications.
1 PENDING PENDING Ibach glaucoma,open angle GL
SNIFFING OUT THE NUGGETS: PEDIATRIC POTPOURRI
Viola Kanevsky, OD & Kenneth Sorkin, OD, FAAO

This course will present six diverse optometric cases involving both congenital and acquired visual conditions. Participants will gain in-depth knowledge about the clinical presentation, incidence, and treatment options for these conditions. The course will focus on practical approaches for diagnosis, management, and emerging therapies.
1 PENDING PENDING Kanevsky pediatrics,children,pharmacology,side effects, medicine FV
THE CHANGING LANDSCAPE OF OCULAR PHARMACOLOGY: WHAT'S NEW AND WHAT'S NEXT
Cecelia Koetting, OD, FAAO, DipABO

This course will present six diverse optometric cases involving both congenital and acquired visual conditions. Participants will gain in-depth knowledge about the clinical presentation, incidence, and treatment options for these conditions. The course will focus on practical approaches for diagnosis, management, and emerging therapies.
2 PENDING PENDING Koetting pharmacology PH
NEW & EMERGING THERAPIES FOR WET AMD
Srinivas Sai A Kondapalli, MD

Age Related Macular Degeneration (AMD) management continues to evolve at lightning speed—in this course we will review new and emerging therapies in clinical trials for AMD.

Course Objectives:
1. Understand the Pathophysiology of Wet AMD
2. Evaluate Current and Emerging Therapeutic Strategies
3. Analyze the Drug Development Pipeline
4. Interpret Clinical Trial Data
5. Forecast Future Trends in Wet AMD Management
1 PENDING PENDING Kondapalli AMD,wet AMD TD
A DAY OF OCTS
Srinivas Sai A Kondapalli, MD

As an every day retina specialist, Dr. Kondapalli sees a lot of OCTs. In this course, we will review a day of OCTs highlighting OCT Biomarkers and features which help diagnosis of a variety of retinal disease.

Course Objectives:
1. Identify common OCT patterns and structural changes associated with major retinal diseases, including diabetic macular edema, AMD, vein occlusions, and CSCR.
2. Recognize and interpret key OCT biomarkers—such as intraretinal/subretinal fluid, DRIL, HRF, and photoreceptor integrity—that correlate with disease activity and visual outcomes.
3. Differentiate active versus inactive or chronic disease states on OCT to guide appropriate management and treatment decisions.
4. Apply practical interpretation skills to real-world OCT cases, improving diagnostic accuracy and patient care in daily retina practice.
1 PENDING PENDING Kondapalli OCT TD
ADVANCING OUR UNDERSTANDING OF GLAUCOMA PROGRESSION
Graham Lakkis, BScOptom, GradCertOcTher, FACO

Detecting significant change in clinical testing, structural analysis and visual field function over time is critical both in glaucoma suspects and those on active glaucoma treatment, as identifying progression at the earliest opportunity allows treatment to be initiated or modified in a more timely manner. The lecture would discuss what is statistically and/or clinically significant change, and the strategies to detect progression at the earliest possible time.
1 PENDING PENDING Lakkis glaucoma,OCT GL
INTRAOCULAR LENSES 2026: PAST, PRESENT AND FUTURE TECHNOLOGY
Jonathan M. Lam, MD, MBA

Cataract surgery is the most frequently performed operation around the globe. Intraocular lens manufacturers have been rolling out a number of premium lenses. New monofocal, adjustable, toric, extended-depth-of-focus (EDOF), and multifocal offerings are available to patients who in the past had no possibility of spectacle independence following cataract surgery. This talk will review the past, present, and future of IOLs.
1 PENDING PENDING Lam IOL, cataract, premium IOL PO
OCULAR AESTHETICS BASICS: IMPROVING BEAUTY AND FUNCTION
Cory J. Lappin, OD, FAAO

This course will cover the overlap between ocular surface health and aesthetics. Conditions that negatively impact the functional and cosmetic aspects of ocular health will be discussed, as well as treatments that address both areas.
1 PENDING PENDING Lappin aesthetics TD
DRUG DELIVERY IN GLAUCOMA 2026
Anupam Laul, OD, FAAO, DIPL ABO

Medications are very important in the management of glaucoma; however, multiple topical drops can often be burdensome to glaucoma patients. Newer drug delivery methods might be the answer in reducing that burden and to improve patient outcomes.

Course Objectives:
1. Learn about research relating to eye drop compliance
2. Understand consequences of poor eye drop compliance
3. Discuss when it is appropriate to use combination medications
4. Review data from commercially available intercameral bimatoprost insert
5. Review data from commercially available travaprost canister
6. Review data from drug eluting IOL currently under study
1 PENDING PENDING Laul Glaucoma GL
FLOATERS: TREATMENT OPTIONS IN 2026
Nate Lighthizer, OD, FAAO

The use of laser energy to treat various ocular conditions has been well established over the years. Floaters are a common ocular pathology that many patients report symptoms from. Traditionally speaking observation and vitrectomy were the two main treatment options for floaters. Emerging technology has promoted interest in utilizing a laser for the treatment of floaters. This interactive presentation will provide an introduction and update regarding utilizing a YAG laser for Laser Floater Removal.
1 PENDING PENDING Lighthizer floaters,laser PO
SLT IN 2026: FIRST LINE? AUTOMATED? ANSWERS TO SLT QUESTIONS
Nate Lighthizer, OD, FAAO

The use of laser energy to treat open angle glaucoma has been used by optometric physicians in certain states for over a decade now. This interactive presentation will review and update these ophthalmic laser procedures.

Learning Objectives:

* Why, and for what ocular conditions, are ophthalmic lasers indicated?
* To review the outcomes and clinical relevance of the Glaucoma Laser Trial.
* To become familiar with the indications, contraindications, treatment protocols, complications, and follow-up with argon laser trabeculoplasty (ALT).
* To become familiar with the indications, contraindications, treatment protocols, complications, and follow-up with selective laser trabeculoplasty (SLT).
* To become familiar with the indications, contraindications, treatment protocols, complications, and follow-up with endoscopic cyclophotocoagulation (ECP).
2 PENDING PENDING Lighthizer Glaucoma, GL, SLT GL
CONTEMPORARY STRATEGIES FOR RISK ASSESSMENT IN POAG: LESSONS FROM CASES
Sarah MacIver BSc, OD, FAAO

This 1-hour lecture will take a case-based approach to emphasize the importance of risk stratification in managing primary open-angle glaucoma (POAG). Risk stratification is essential in deciding when to start treatment and determining follow-up frequency, ensuring early detection and timely intervention.

This session will provide an updated, contemporary look at clinical considerations such as systemic, non- IOP risk factors, incorporation of iCare home, and AI. The session will aid In providing practical, evidence-based strategies for clinicians to guide patients in making lifestyle modifications that may reduce risk or slow disease progression.
1 PENDING PENDING MacIver glaucoma,risk,POAG,OHTN, MIGS GL
WHEN DROPS AREN'T ENOUGH: ORAL MEDICATIONS IN GLAUCOMA
Sarah MacIver BSc, OD, FAAO

This course explores the therapeutic role of oral medications in glaucoma management when topical treatment is insufficient or contraindicated. Clinicians will review the pharmacology, indications, and contraindications of oral carbonic anhydrase inhibitors and systemic agents used in acute or complex glaucoma presentations. Case-based discussions will illustrate scenarios such as uveitic glaucoma and acute primary angle closure where systemic therapy can play a critical role in IOP control.
1 PENDING PENDING MacIver glaucoma,pharma,risk,POAG,OHTN, MIGS GL
SHARPER THAN EVER: THE SECRET SAUCE OF SCLERAL LENS OPTICS
Charles A. McBride, OD

The description of light as a wavefront, and how scleral lenses affect a complex wavefront, including lower order and higher order aberrations.

Course Objectives
1. Understanding why it is useful to describe light at a wavefront.
2. To understand the difference between lower and higher order aberrations.
3. To review the optics of surfaces in relation to refractive index.
4. To describe a means of incorporating the correction for higher order aberrations into scleral lens optics.
1 PENDING PENDING McBride sclerals, contact lenses,optics CL
THE ULTIMATE TBI FIRST AID KIT
Vittorio Mena OD, MS

Description: When someone suffers a traumatic brain injury it can potentially lead to short-term or long-term health problems and also a major cause of death and disability. This lecture will take a deep dive of what you need to do immediately in order to recover from a traumatic brain injury.

Course Objectives:
1. Identify the causes and effects of traumatic brain injuries
2. Discuss ways to minimize cell death and inflammation in the brain to keep you functioning and alive
3. Discuss the importance of vision rehabilitation and cognitive testing after a traumatic brain injury
1 PENDING PENDING Mena concussion SD
BEYOND PAIN RELIEF: THE OPIOID EPIDEMIC AND EYE CARE IN 2026
Thuy-Lan Nguyen OD, FAAO, FSLS

Opioid drugs act on the brain to provide pain relief. They include prescription medications such as oxycodone, hydrocodone, codeine and morphine as well as illicit drugs such as heroine and fentanyl. At the conclusion of this lecture, attendees will understand the opioid epidemic as well as ocular and systemic signs of opioid use disorder.
2 PENDING PENDING Nguyen opioids,narcotics,DEA,pain PH
GEN Z AND OPTOMETRY
Thuy-Lan Nguyen OD, FAAO, FSLS

Generation Z, born from the mid 90's to the early 2010's, is reshaping the future of optometry as patients and the next wave of eye care professionals. This course will explore the values, communication styles and digital expectations that define Gen Z. This course will discuss how these traits influence practice culture and patient engagement. Attendees will gain practical strategies to attract, retain, and motivate Gen Z patients and employees.
1 PENDING PENDING Nguyen GenZ PM
THE EYE AS A WINDOW: DETECTING SYSTEMIC DISEASE IN THE EXAM LANE
Ada Noh, OD

Explore how ocular findings can reveal underlying systemic diseases. This course highlights key diagnostic clues seen in the anterior and posterior segments, connecting eye health to whole-body conditions. Learn to recognize, interpret, and manage ocular manifestations of systemic disorders to enhance patient care and interdisciplinary collaboration.

Course Objectives:
1. Identify common ocular manifestations of systemic diseases encountered in optometric practice.
2. Differentiate between primary ocular conditions and signs of systemic involvement.
3. Recognize when to refer patients for systemic evaluation or co-management.
4. Understand the pathophysiologic links between systemic diseases and ocular findings.
5. Integrate systemic health considerations into routine comprehensive eye examinations.
6. Enhance communication and collaboration with other healthcare providers for improved patient outcomes.
1 PENDING PENDING Noh Dry eye, OSD, ocular surface disease TD
SEEING THE FUTURE: NUTRITION'S ROLE IN DELIVERING HEALTH 3.0
John Nolan, PhD

This lecture provides optometrists with practical, evidence-based guidance on how to optimize visual performance and ocular health through targeted nutrition. Participants will learn how key nutrients, particularly carotenoids and omega-3 fatty acids support retinal function, reduce oxidative stress, and enhance both visual and cognitive outcomes.

The session will also explore how incorporating nutritional assessment and counselling into routine primary eye care can strengthen patient outcomes and practice value. Finally, the lecture introduces the concept of Health 3.0, illustrating how optometrists can lead in a new era of preventive, personalized, and patient-empowered healthcare.
1 PENDING PENDING Nolan nutrition,ocular disease,cardiometabolic disease PB
SMALL PATIENTS, BIG CHANGES: WHAT'S NEW IN PEDIATRIC EYECARE AND WHY IT MATTERS
Tamara Petrosyan, OD

As myopia rates soar among children due to modern lifestyles, eye care professionals face new challenges in preventing lifelong vision complications.

This session delves into the latest consensus statements redefining myopia as a progressive disease, explores new evidence-based interventions like advanced optical therapies that slow progression, and highlights innovative tools from gene editing to new pediatric dry eye management and AI tools, equipping you with practical insights to enhance patient outcomes in everyday practice.
1 PENDING PENDING Petrosyan pediatrics FV
TINY EYES, BIG ISSUES: NAVIGATING OCULAR DISEASE IN PEDIATRIC EYE CARE
Tamara Petrosyan, OD

This lecture is designed to enhance primary care optometrist's expertise in identifying and treating common pediatric anterior segment conditions likely to sit in your chair. We will review practical insights on diagnostics, topical and oral pharmacological interventions (including contraindications and dosing), and referral criteria.

Upon completion of this lecture, participants will be able to:
1) Identify the clinical signs, symptoms, and differential diagnoses for anterior segment diseases commonly encountered in pediatric patients
2) Evaluate appropriate diagnostic tools and examination techniques tailored to pediatric patients for ocular conditions.
3) Select and prescribe evidence-based treatments, including topical and oral medications with age-specific dosing, while considering contraindications and off-label applications.
2 PENDING PENDING Petrosyan pediatrics TD
PAIN MANAGEMENT: NARCOTIC ANALGESICS AND BEYOND!
Joseph Pizzimenti, OD, FAAO and Carlo J. Pelino, OD, FAAO

This course provides current and accurate information about the judicious use of controlled substances in optometry. Pain is a feeling triggered in the nervous system. It may be sharp or dull. Pain may come and go, or it may be constant.

We present the pathobiology, causes, proper diagnosis, and responsible management of ocular and periocular pain. While the opioid class of analgesics remains an important component of mitigation of pain, our discussion goes beyond narcotic analgesics to discuss a global approach to pain management.
2 PENDING PENDING Pizzimenti narcotics,dea,pain PH
TRUE EMERGENCIES OF THE POSTERIOR POLE
Carlo J. Pelino, OD, FAAO and Joseph Pizzimenti, OD, FAAO

This course highlights the true ocular emergencies that present in the posterior pole. We review clinical findings, appropriate systemic testing, treatment and management of each emergency. We also discuss new treatment options and specific testing for each condition. This course will be presented in a grand rounds fashion, with clinical cases illustrating the use of systemic testing and neuroimaging when appropriate.

Objectives:
1. To list 5 true emergencies of the posterior pole.
2. To recognize, diagnose, and manage BRAO and CRAO.
3. To recognize, diagnose, and manage Arteritic AION.
4. To discuss the ocular manifestations of giant cell arteritis.
5. To effectively use neuroimaging when appropriate.
6. To define true papilledema.
7. To accurately diagnose and manage hypertensive crisis.
2 PENDING PENDING Pelino posterior pole, emergency, diagnosis, management TD
DRY EYE OVERLOAD: WHERE DO YOU EVEN BEGIN?
Jessilin Quint OD, MBA, MS, FAAO

With countless drops, devices, and drug options now available, managing dry eye can feel overwhelming. This lecture provides a practical, stepwise framework to help clinicians cut through the chaos. This framework includes identifying the root cause, prioritizing treatments, and building an evidence-based, personalized management plan that actually works.

Course Objectives:
1. Discuss at home therapy options for Dry Eye Disease.
2. Discuss modern in-office treatment options for Dry Eye Disease.
3. Discuss pharmacological treatment options for Dry Eye Disease.
1 PENDING PENDING Quint dry eye,ocular surface TD
SHARPENING YOUR OCT SKILLS: PRACTICAL PEARLS FOR OPTOMETRISTS
Mohammad R. Rafieetary, OD, FAAO

Enhance your interpretation skills with this practical, case-based session focused on OCT imaging. Learn to recognize key retinal and optic nerve findings, avoid common pitfalls, and apply imaging insights to improve patient care and co-management decisions.

Objectives:
1) Identify characteristic OCT patterns of common retinal and optic nerve disorders.
2) Differentiate normal anatomical variations from pathologic findings on OCT scans.
3) Understand anatomic vs analytic findings, pros and cons of each of these in OCT imaging
4) Apply OCT interpretation skills to guide diagnosis, management, and appropriate referral decisions in optometric practice.
1 PENDING PENDING Rafieetary OCT, retina TD
OCULAR MANIFESTATIONS OF GLP 1/GLP 1+GIP DRUGS
Julie Rodman, OD, MSc, FAAO

GLP-1 receptor agonists are widely prescribed for the management of Type 2 diabetes and obesity. Numerous reports have cited ocular side effects associated with their usage.

The most frequently reported complications include non-arteritic ischemic optic neuropathy, diabetic retinopathy, links to macular complications, changes in intraocular pressure, refractive shifts and dry eye.

Overall, while GLP-1RAs provide significant systemic benefits, careful ophthalmic monitoring, particularly in high-risk patients is recommended. This course will review the pathophysiology of GLP-1 RAs and investigate the link between these medications and ocular side effects. Case examples will be highlighted.
1 PENDING PENDING Rodman GLP-1 PH
IN THE CENTER OF VISION: A DEEP DIVE INTO MACULAR DISORDERS
Julie Rodman, OD, MSc, FAAO

This course provides an overview of macular disorders with a focus on multimodal imaging. Emphasis will be placed on differential diagnosis of disease including the role of OCT and FAF in disease monitoring, and treatment planning.

By integrating structural and functional imaging, attendees will gain a deeper understanding of how OCT and FAF contribute to differentiating macular pathologies, assessing progression, and guiding patient care. Topics will include macular telangiectasia, vitelliform dystrophy, acute macular neuroretinopathy, and central serous chorioretinopathy.
1 PENDING PENDING Rodman macula TD
CASE CLOSED? NOT SO FAST - UNCOVERING THE CLUES HIDDEN IN YOUR CASES
Justin Schweitzer, OD, FAAO

This case-based lecture will share pearls on decision making for the glaucoma patient. An emphasis will be placed on evidence-based management strategies for the glaucoma patient.

Course Objectives:
1. To understand the use and reasoning of ordering 10-2 visual fields.
2. To review the structure and function relationship in glaucoma based on OCT's and visual fields.
3. To understand various treatment options in glaucoma including topical glaucoma medications, SLT, glaucoma drug delivery, and MIGS.
4. To understand various treatment considerations centered around treating patients with normal tension glaucoma.
1 PENDING PENDING Schweitzer glaucoma GL
OCULOMICS: AI AND THE EYE AS A WINDOW INTO SYSTEMIC HEALTH
Steve Silberberg, OD

This one-hour lecture introduces oculomics—using ocular biomarkers to detect and monitor systemic disease. Topics include current evidence, FDA-cleared technologies, applications in diabetes, cardiovascular disease, neurodegeneration, and the role of AI in retinal image analysis. Practical strategies highlight optometrists’ expanding role in systemic disease detection,

At the conclusion of this course, participants will be able to:
1. Define oculomics and explain the value of retinal biomarkers in systemic health assessment.
2. Identify key systemic diseases detectable through ocular imaging (e.g., diabetes, cardiovascular disease, neurodegeneration).
3. Describe the role of artificial intelligence in enhancing retinal image analysis for multi-disease screening.
4. Recognize current FDA-cleared technologies and their applications in clinical optometry.
5. Apply practical strategies for incorporating oculomics into routine practice, including referral pathways and patient education.
1 PENDING PENDING Silberberg AI,Artificial Intelligence, diagnostics GO
CORNEAL SIDE EFFECTS OF SYSTEMIC MEDICATIONS
Steven Sorkin, OD

Many drugs can damage the cornea, and drug-induced changes can range from asymptomatic deposits that are incidental findings during an examination to irreversible changes that can be life threatening. This can affect a single layer or multiple layers. This course will review some common (and not so common) systemic medications that can cause changes to the cornea.
1 PENDING PENDING Sorkin pharmacology, erosions PH
CORNEAL DYSTROPHIES 101
Steven Sorkin, OD

Corneal Dystrophies are very commonplace in the optometric practice. This course will review the clinical presentations and medical and surgical treatment of these frequently visually debilitating conditions.

COURSE OBJECTIVES:
1) Review clinical presentations of corneal dystrophies
2) Review genetic characteristics of corneal dystrophies
3) Discuss medical and surgical treatments for corneal dystrophies
1 PENDING PENDING Sorkin cornea, corneal dystrophies TD
CORNEAL DYSTROPHIES 101
Steven Sorkin, OD

Corneal Dystrophies are very commonplace in the optometric practice. This course will review the clinical presentations and medical and surgical treatment of these frequently visually debilitating conditions.

COURSE OBJECTIVES:
1) Review clinical presentations of corneal dystrophies
2) Review genetic characteristics of corneal dystrophies
3) Discuss medical and surgical treatments for corneal dystrophies
1 PENDING PENDING Sorkin cornea, corneal dystrophies TD
YOU'RE OLD: NEW OPTIONS FOR THE UNAVOIDABLE REFRACTIVE ERROR
Marc R. Bloomenstein, OD, FAAO

The new presbyopia treatments are all the rage. However, will all patients see the value in ditching their current treatment? Is everyone a good candidate? This course will look at how to approach the inevitable, presbyopia.

Learning objectives
1. Learn about the theory behind presbyopic drops
2. Review optimal patient types for presbyopia therapy and or surgery
3. Cover troubleshooting techniques to increase success
1 PENDING PENDING Bloomenstein presbyopia TD
NAVIGATING GLAUCOMA’S DEPTHS: FROM PATHWAYS TO PRECISION CARE
Jessica Steen, OD

This course will dig into first principles and physiological understanding of glaucoma in order to best understand and apply current management strategies including medication, SLT, sustained release options, and surgical procedures.

Advances in understanding of pathophysiology, genetics, and the goal of development of disease-modifying therapies are highlighted.

At the conclusion of this course, attendees will be able to:
1) Understand the location of pathology in open angle glaucoma
2) Address therapeutic strategies and their mechanism in the management of glaucoma
3) Apply medical evidence through recent notable publications into clinical care
1 PENDING PENDING Steen glaucoma GL
DYSFUNCTIONAL LENS SYNDROME
Shaina Sullivan, OD

This course will describe dysfunctional lens syndrome and increased higher-order aberrations due to lens aging. Patient cases will be reviewed with emphasis on how higher-order aberrations affect clinical decision-making.

Course Objectives
1. To review aging stages of the lens and dysfunctional lens syndrome.
2. To review Zernike polynomials and higher-order aberrations.
3. To differentiate between devices used to measure higher-order aberrations.
4. To recognize the impact of higher-order aberrations on visual outcomes.
5. To discuss refractive and surgical management of dysfunctional lens syndrome.
1 PENDING PENDING Sullivan dysfunctional lens syndrome TD
PHACO PEARLS: SWEAT THE DETAILS
Tracy Schroeder Swartz, OD, MS, FAAO

Discussion of what a surgeon considers during a cataract evaluation. Discussion includes what sending patients ready for surgery is critical given the reduction in ophthalmologists in the US, and clinical considerations such as ocular surface, CL history, pupil size, retinal health status, systemic health conditions, medications and current refractive error. Previous refractive surgery and surgical staging will also be covered.

Goals:
1) Understand how prepare a patient for referral based upon what a surgeon considered during surgical evaluation
2) Consider how anatomy affects cataract surgery
3) Consider how systemic health affects cataract surgery
4) Understand how medications affect cataract surgery
5) Consider how ocular history may affect cataract surgery
6) Understand how anatomy affects cataract surgery
1 PENDING PENDING Swartz cataracts PO
INTERVENTIONAL OPTOMETRY: MAKE A PURPOSEFUL IMPACT
Tracy Schroeder Swartz, OD, MS, FAAO

This talk is a discussion around new shifts in interventional optometric practice. This includes an introduction to interventional medicine, followed by discussion of our active roles in myopia control, anterior segment disease, glaucoma and keratoconus. Lecture will review the 2025 Interventional glaucoma Consensus Treatment Protocol published in March 2025.

Course Objectives
1. Define Interventional medicine
2. Understand nonmedical and early interventions
3. Understand Interventional myopia
4. Understand Interventional anterior segment management
5. Understand Interventional glaucoma
6. Understand Interventional keratoconus
1 PENDING PENDING Swartz interventional optometry TD
PRISM PEARLS: PRACTICAL PRESCRIBING STRATEGIES FOR ADULT DIPLOPIA
Jacqueline Theis, OD, FAAO, FNAP

This lecture will review key principles and clinical pearls for prescribing prism in adults with diplopia. Emphasis will be placed on when to prescribe, how to determine the appropriate amount and type of prism, and strategies to maximize comfort and function while avoiding common pitfalls, Redos and missing emergencies.

Course Objectives
1. Identify key clinical indications and contraindications for prism prescribing in adults with diplopia, including red-flag presentations suggestive of urgent neuro-ophthalmic pathology.
2. Apply variety of didactic vs. clinical methods for calculating and trialing prism power at distance and near, including fixation disparity, trial-framing, and patient-adaptation techniques.
3. Develop practical management strategies to maximize visual comfort and binocular function while minimizing adaptation issues, suppression, and symptomatic decompensation.
4. Review diagnosis and management of adult diplopia using cases including exophoria, esophoria, vertical phoria, and cranial nerve palsies
1 PENDING PENDING Theis prism, diplopia FV
PEDIATRIC CONDITIONS THAT YOU CAN MANAGE AND TREAT ON YOUR OWN!
Lance Underwood, OD

This course enables optometrists to accurately diagnose, manage, and treat common pediatric ocular conditions. Participants will learn evidence-based approaches to corneal disease, infection, inflammation, and strabismus, emphasizing long-term care, patient education, hygiene compliance, and treatment strategies to promote optimal visual development and ocular health in children.

Upon completion of this course, participants will be able to:
1. Identify and differentiate common pediatric corneal and eyelid conditions.
2. Develop evidence-based treatment and follow-up protocols tailored to pediatric patients.
3. Implement effective communication strategies to educate parents and children on hygiene, compliance, and prevention of recurrent ocular surface disease.
4. Recognize when to initiate pharmacologic, procedural, or surgical interventions for various conditions.
5. Manage pediatric strabismus and amblyopia through accurate refraction, patching, and follow-up care to support proper visual development
1 PENDING PENDING Underwood pediatrics TD
HOT POTATOES: URGENT DIAGNOSES, TREATMENTS AND REFERRALS
Richard Witlin, MD, FACS

Using actual clinical examples, this course is designed to present situations in which Emergency care, treatment and/or immediate referral for advanced care is necessary. Attendees will need to diagnose the clinical situations being presented and then propose appropriate action to be taken.

Topics covered include: Dislocated Lasik Flap, Sudden Onset of Diplopia, Post-operative hyphema, Management of ocular foreign bodies, Medication-induced acute angle closure glaucoma (ACG), Anterior Ischemic Optic Neuropathy (AION), Central Retinal Artery Occlusion (CRAO), and Acute Onset of a Painful Swollen Eye
1 PENDING PENDING Witlin Anterior Segment TD
VISIONARY ADVANCES: EMERGING THERAPIES FOR AGE-RELATED MACULAR DEGENERATION
Mary Beth Yackey, OD

Emerging therapies for age-related macular degeneration (AMD) include longer-lasting anti-VEGF drugs, gene and combination therapies for wet AMD. Also, new FDA-approved treatments and stem cell research for dry AMD—offering hope for more effective, less invasive, and potentially regenerative care.

By the end of this course, you will be able to:
1. Describe the pathophysiology and clinical presentation of both wet and dry forms of age-related macular degeneration (AMD).
2. Explain the mechanisms of action and therapeutic roles of anti-VEGF agents in managing wet AMD.
3. Evaluate the benefits and limitations of current AMD treatments, including injection frequency and patient burden.
4. Analyze emerging therapies such as gene therapy, combination treatments, and stem cell approaches for AMD.
5. Discuss the significance of recent FDA-approved drugs targeting the complement cascade in dry AMD.
6. Assess the potential impact of innovative AMD treatments on patient quality of life and long-term disease management.
7. Interpret clinical trial data and research findings related to AMD therapies and future directions in treatment for AMD.
1 PENDING PENDING Yackey AMD TD
OPIATES AND OCULAR PAIN MANAGEMENT
Marc D. Myers, OD, FAAO and Andrew S. Gurwood, OD, FAAO, Dipl.

Description: Discussion of the mechanism of pain associated with diagnoses of the ocular adnexa, orbit, and globe. Presentation of treatment modalities used to manage pain associated with ocular disease. Discussion of the therapeutic use of opiate medications in the management of ocular disease.

Objectives:
Discussion of the mechanism of pain associated with diagnoses of the ocular adnexa, orbit, and globe. Presentation of treatment modalities used to manage pain associated with ocular disease. Discussion of the therapeutic use of opiate medications in the management of ocular disease.
2 PENDING PENDING Myers opioids, DEA PH

Speakers

Kayla Ashlee is the founder of Spexy, an international optometric speaker, a certified optician, and an optometric renegade. Her direct and relatable approach to training has set her apart in the optical industry. Kayla took her knowledge of industry coaching and adapted it to reach any eyecare office that is hungry to grow by putting her training in an online video learning platform called Spexy® The result, she and her team train opticals how to give a sensational experience to their patients and it is transforming the patient relationship with their optical in a powerful way.

She also created a tool called FrameTurn® for independent opticals. It allows opticals to have access to frame inventory coaching and guidance based upon each optical’s unique sales numbers and has proven to be a massive profit builder for the independent! To learn more about her visit www.beSpexy.com.
Roya Attar, OD, MBA, DHA, FAAO Roya Attar serves as an Associate Professor and Director of Optometric Services at the University of Mississippi Medical Center in Jackson, MS. As the sole optometrist at the state's only medical school, she strives to make a meaningful impact on patient care, education, and leadership.

Beyond her primary responsibilities, Roya is deeply committed to providing comprehensive clinical care, sharing knowledge with residents, and ensuring the smooth operation of optical services. With dual Doctorates in Optometry and Health Administration, complemented by a Master's in Business Administration, she actively pursues ongoing growth and development in her role.

A distinguished Fellow of the American Academy of Optometry, Roya assumes pivotal roles, including chairing the AAO Retina Special Interest Group and serving as the vice chair of the AOA Leadership Development Committee. In addition, she is president of her local society, where she contributes to discussions on best practices and professional development.

Though grateful for recognition and numerous accolades, including awards like Mississippi Young OD of the Year, SECO Young OD of the Year, AOA Young OD of the Year, and Women in Optometry Young OD of the Year, she remains focused on serving others and committed to advancing the optometric profession.
Melissa Barnett, OD, FAAO, FSLS, FBCLA is a world-renowned key opinion leader recognized for her expertise in dry eye disease, specialty and scleral lenses, keratoconus and presbyopia. She has authored more than 300 articles and books, delivered over 500 lectures, is a board member and founding member of Intrepid Eye Society and serves on several industry boards.

Dr. Barnett is the author and editor of Specialty Contact Lenses and Contemporary Scleral Lenses: Theory and Application, which features insights and contributions from leading international experts. Her work has been featured in medical journals, professional magazines, as well as consumer publications such as The Washington Post, Bloomberg, Prevention Magazine, and Good Housekeeping. Dr. Barnett is an Associate Certified Coach (ACC), credentialed by the International Coaching Federation (ICF). She specializes in mindful leadership, wellness, and public speaking, empowering individuals to become their best selves in both their personal and professional lives.

She is energized by her passion for helping people improve their lives by optimizing their vision, health and wellness with a customized approach. Dr. Barnett is most proud of being awarded the Legends Award from AOA CLCS, the Scleral Lens Practitioner of the Year from the Scleral Lens Education Society, the inaugural Theia Award for Excellence for Mentoring by Women In Optometry and was granted the Most Influential Women in Optical from Vision Monday. Dr. Barnett is the host of the Clearly KC and Starting Strong podcasts. She advocates for elevating eye care through technology and her influence on the profession.
Marc R. Bloomenstein, OD, FAAO is a 1990 graduate of the University of California at Los Angeles with a degree in Biology. He received his optometric degree from the New England College of Optometry in 1994. After graduation Dr. Bloomenstein finished a residency in secondary ophthalmic care at the Barnet Dulaney Eye Center in Phoenix, Arizona. He received his fellowship from the American Academy of Optometry in December 1998.

Currently Dr. Bloomenstein is the Director of Optometric Services at the Schwartz Laser Eye Center in Scottsdale, Arizona and President of MRB Eye Consultants. Dr. Bloomenstein is on the editorial board of Primary Care of Optometry News, Review of Optometry, Optometry Times, Modern Optometry, Optometric Management and a frequent contributor to other various optometric journals.

Dr. Bloomenstein served as the Chairman of the AOA Continuing Education Committee and served on the board of the Ocular Surface Society of Optometry (OSSO), as well as a founding member of the Optometric Cornea, Cataract, and Refractive Society (OCCRS). Dr. Bloomenstein has served as the President of the Arizona Optometric Association, Legislation Chair and President of the Board of the Arizona Optometric Charitable Foundation. Dr. Bloomenstein has delivered over 1500 invited lectures worldwide and serves as a consultant to numerous industry-leading pharmaceutical, biomedical and information technology companies.
Shelby Brogdon, OD, is a native Arkansan, practicing at McFarland Eye Care in Little Rock. Dr. Brogdon loves seeing patients of all ages and is passionate about leading her practice's Dry Eye Clinic. She is an active member of the Arkansas Optometric Association where she serves on several committees and is a graduate of its LEADership program.

Dr. Brogdon graduated from the University of the Incarnate Word, Rosenberg School of Optometry.

She was named a Contact Lens Institute Visionary in 2024, a role which she uses to raise awareness regarding contact lens health and safety by promoting best practices tools, tips and research through CLI's The EASY Way program and See Tomorrow initiative.
Kristen Brown, OD, FAAO is a provider and Chief Operating Officer of Eyewell. She completed her clinical training at the University of California, School of Optometry in 1992. After completing two Ocular Disease Residencies and a 2-year Fellowship in Ocular Disease, Dr. Brown completed a Research Fellowship at the Boston University School of Medicine.

She holds academic appointments as Associate Professor of Clinical Optometry at the New England College of Optometry and the MCPHS School of Optometry. Prior to Eyewell, Dr. Brown served as the Associate Dean of Clinical Affairs at the New England College of Optometry and was the Clinical Director at TLC Laser Centers, where she oversaw two high-volume laser refractive and cataract surgery centers and developed clinician networks between optometrists and ophthalmologists throughout New England.

Dr. Brown is a member of the American Optometric Association and the Massachusetts Society of Optometrists. She is a Diplomate in the Cornea, Contact Lens and Refractive Technology Section of the American Academy of Optometry. Her clinical and research interests focus on dry eye management and diseases that affect the tear film and ocular surface.
Mile Brujic, OD, FAAO is a 2002 graduate of the New England College of Optometry. He is a partner of Premier Vision Group, a successful three location optometric practice in Northwest Ohio.

He practices full scope optometry with an emphasis on ocular disease management of the anterior segment, contact lenses and glaucoma. He is active at all levels of organized optometry.

Dr. Brujic is on the editorial board for a number of optometric publications. He has published over 250 articles and has given over 1400 lectures, both nationally and internationally on contemporary topics in eye care.
Lorcan Butler, BSc (Hons), MCOptom is an optometrist and dispensing optician from Bangor, County Down, Northern Ireland. He works with The Brain Tumour Charity where he is responsible for aiding practitioners in identifying and managing patients with signs and symptoms that may be associated with a brain tumour.

Lorcan has spoken extensively at optical conferences throughout the UK and Ireland. He has worked with numerous optical bodies and organisations including the AOP, ABDO, Optometry Wales, Optometry Northern Ireland and the European Academy of Optometry and Optics.
Benjamin P. Casella, OD is a third-generation optometrist who owns and operates Casella Eye Center in Augusta, GA, which was established in 1948 by his grandfather, Victor. After graduating from the University of Alabama at Birmingham School of Optometry and completing his residency at State University of New York College of Optometry, Dr. Casella joined the family practice in 2008, continuing the tradition of providing quality care to the local community alongside his father.

In addition to managing the family practice, Dr. Casella serves as the chief optometric editor of Optometry Times®. He is very active within the professional optometric community, holding many positions within the Georgia Optometric Association, serving on the AOA Evidence Based Optometry Committee, and having been named the Young OD of the South by SECO International in 2014.
A. Paul Chous, MA, OD, FAAO Dr. Paul Chous has a private practice specializing in diabetes eye care and education in Tacoma, WA and is Adjunct Professor of Optometry at Western University of Health Sciences in Pomona, CA. He completed his undergraduate education at Brown and UC Irvine, and then received his Masters and Doctorate of Optometry degrees from UC Berkeley.

He is the author of Diabetic Eye Disease: Lessons From a Diabetic Eye Doctor, which was included in the “Top 12 Diabetes Books” by Diabetes Update magazine in 2004. He is editorial advisor to Review of Optometry and Optometry Times, AOA representative to the National Diabetes Education Program, Primary Investigator for the Diabetes Visual Function Supplement Study (DiVFuSS), and was named one of the 250 most influential optometrists in 2017. Dr. Chous has had type 1 diabetes since 1968.
Pinakin Davey, OD, PhD, FAAO is a tenured full Professor at Western University of Health Sciences, College of Optometry. He holds Doctor of Optometry (OD) degree from Southern College of Optometry and a Ph.D. from Anglia Ruskin University in Cambridge, England. His post-doctoral research fellowship at University of Louisville for three years was focused on improving imaging techniques in glaucoma.

His research is focused on retinal physiology and glaucoma particularly improving visual function in disease states. He has authored over 75 international publications and has given over 300 conference and invited presentations both nationally and internationally. His research work is funded in past and present by the National Institute of Health and industry sponsored FDA trials.
Mark Friedberg, MD graduated with top honors from Brown University Undergraduate and was selected to the medical honor society at the University of Pennsylvania School of Medicine. Dr. Friedberg was also chosen to be one of 12 residents at the renowned Wills Eye Hospital where he did his training.

He was then selected to be the coveted, sole retinal trainee for the Washington National Eye Center located at the Washington Hospital Center.

He is the co-founding editor and original lead author of the best selling book in ophthalmology, The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease. Dr. Friedberg has also published numerous articles on eye surgery, has given dozens of lectures to societies of eye doctors, and has been a reviewer for eye journals in the past. He has served as a consultant to over 100 eye doctors and has performed thousands of eye operations.
Ben Gaddie, OD, FAAO earned his Doctor of Optometry degree from the University of Alabama-Birmingham School of Optometry. He further honed his expertise with a residency in ocular disease through Northeastern State University College of Optometry at Triad Eye Medical Clinic and Cataract Institute in Tulsa, OK. He is the proud owner and director of Gaddie Eye Centers, a renowned multi-location practice established by his father more than four decades ago.

As a fellow of the American Academy of Optometry and former president of the Optometric Glaucoma Society, Dr. Gaddie is actively involved in advancing the field of optometry. He currently co-chairs the International Vision Expo meetings and has held past leadership roles, including president of the Kentucky Optometric Association. His extensive contributions to ophthalmic literature are reflected in his editorial roles with Review of Optometry, Optometric Management, Primary Care Optometry News, and Optometry Times.

In 2011, Dr. Gaddie was inducted into the Oklahoma Pioneers in Optometry Hall of Fame, recognizing his impact on the field. He was also honored as one of the Most Influential in Optometry by Optometric Management in 2015. He was also named a "Leader in Sight" by Bausch & Lomb and received the Kentucky Optometric Association Optometrist of The Year award. His recent works include influential articles on glaucoma and insights from legendary optometris
Susan Gromacki, MS, OD, FAAO, FSLS is an internationally-recognized clinician, lecturer, and author in optometry. In practice for 31 years, she graduated with honors from the University of Notre Dame and The Ohio State University College of Optometry and completed a residency in hospital-based optometry with the U.S. Department of Veterans Affairs.

She has presented over 800 professional lectures and publications and has served as Contributing Editor of Contact Lens Spectrum, Review of Cornea and Contact Lenses, Contemporary Optometry, and CL Today.

She serves on the National Board of Examiners in Optometry, composing and overseeing the written examinations that ensure the qualifications of new US optometrists to enter practice. She is one of only 24 doctors worldwide to earn both a Fellowship in the Scleral Lens Education Society and the prestigious Diplomate in Cornea, Contact Lenses and Refractive Technologies of the American Academy of Optometry.

She has presented on behalf of the profession of optometry to the US FDA and FTC, and in countries around the world.

Formerly a faculty member of the New England College of Optometry and the University of Michigan Medical School, Department of Ophthalmology, she has received almost 50 professional awards for excellence, including the “Top Doctor of 2024” Award from the National Keratoconus Foundation, the Contact Lens Institute (CLI) Culture Award (2023), the 2022 Albert Nelson Marquis Lifetime Achievement Award, the World’s Top Optometrists (2020) and one of the Most Notable Alumni in the 100-year history of The Ohio State University College of Optometry. She currently practices at First Sight Vision Care in Fulton, MD.
Andrew Gurwood, OD, FAAO graduated from Indiana University of Pennsylvania in 1984. Following his undergraduate education he entered the Pennsylvania College of Optometry and received his Doctor of Optometry degree in 1989. He completed a one year post-graduate residency at The Eye Institute in 1990. In addition to his clinical practice at The Eye Institute, he also maintains at practice in the Department of Ophthalmology at Albert Einstein Medical Center in Philadelphia

Dr. Gurwood is a Diplomate of the American Academy of Optometry. He is a member in good standing of the American Optometric Association and the Pennsylvania Optometry Association. In 1998 he was recognized by the American Optometric Association as “Young Optometrist of the Year.” The Pennsylvania Optometric Association recognized him in 2006 as the state's "Optometrist of the Year."

Dr. Gurwood has published extensively in optometric journals, and has authored textbook chapters, as well as entire professional texts. He currently serves on the numerous editorial boards including The Journal of The American Optometric Association (Optometry), The Southern Journal of Optometry, and the Review of Optometry. Dr. Gurwood continues to lecture extensively throughout the country on his areas of professional expertise, internal and external ocular disease.
Mitchel J. Ibach, OD, FAAO is a residency trained optometrist at Vance Thompson Vision in Sioux Falls, SD. Dr. Ibach attended the Pacific University College of Optometry where he graduated summa cum laude. Mitch completed his residency training at Minnesota Eye Consultants with a concentration on cornea, refractive surgery, external disease and glaucoma.

In September of 2014, he joined Vance Thompson Vision to focus on advanced anterior segment surgery care and pathology. Mitch is a fellow of the American Academy of Optometry, an Intrepid Eye Society member, a member with the American Optometric Association, Optometric Glaucoma Society (OGS), and the South Dakota Optometric Society. Dr. Ibach is the residency co-coordinator at Vance Thompson Vision, and is also an adjunct clinical faculty for the Illinois College of Optometry and the Pikesville College of Optometry
Viola Kanevsky, OD is a pediatric optometrist specializing in custom contact lenses, who has practiced on the Upper West Side of Manhattan for almost 30 years.

An émigré from the former Soviet Union, Dr. Kanevsky lived in Netanya, Brussels, and Miami, until her family settled in New York City in 1979. Many years later, having earned a BS from Pace University and a Doctorate from SUNY State College of Optometry, she works and lives with her husband, daughter, and son in the neighborhood that she loves best.

She is the immediate past President of the New York State Optometric Association and has served on its board in various capacities for several years; she has served as director of the Optometric Society of the City of New York. She is the president of the NY chapter of Volunteer Optometric Services to Humanity (VOSH) and has joined VOSH on medical missions to orphanages in Mexico, Peru and Guatemala.

In 2022, Dr. Kanevsky ranked #1 on Newsweek’s list of America's Best Eye Doctors.
Cecelia Koetting, OD, FAAO, DipABO is an Assistant Professor at the University of Colorado School of Medicine in the Department of Ophthalmology in Denver, CO. Her primary focus is in anterior segment and ocular surface disease, neuro-optometry, and peri-operative care. She partakes in clinical research and has served Externship Director and adjunct faculty for several schools and colleges of optometry.

Dr. Koetting is a member of Intrepid, a fellow in the American Academy of Optometry, a diplomate of the American Board of Optometry, an active member of AOA and has served as both local and state officers within AOA. She was named young Optometrist of the year by the state of Virginia. Dr. Koetting lectures locally, nationally and internationally at conferences, continually contributes articles to and serves on editorial board for multiple publications.
Srinivas Sai Kondapalli, MD is a senior partner and retina specialist at Everett and Hurite Ophthalmic Association in Pittsburgh, PA. He is also the founder of Rinsada, an irrigating eyelid retractor. A Cleveland, Ohio native, he graduated from The Ohio State University and received his medical degree from The Ohio State University College of Medicine.

Dr. Kondapalli completed his ophthalmology residency at Loyola University Medical Center in Chicago, Illinois. He then returned to Ohio to complete a fellowship in medical retina and ocular oncology in through The Havener Eye Institute at The Ohio State University Wexford Medical Center. He has extensive experience in treatment of macular degeneration, retinal vein occlusions, and diabetic retinopathy. He was actively involved in clinical trials and is up to date on the most current treatment modalities.
Graham Lakkis, BScOptom, GradCertOcTher, FACO owns a private practice in East Victoria, Australia, with a clinical focus on ocular disease management and glaucoma treatment.

Graham also holds positions as a Senior Fellow at the University of Melbourne Department of Optometry and Vision Science, and Lead Optometrist at the University of Melbourne Glaucoma Clinic.

He is a member of the Optometry Board of Australia's Scheduled Medicines Advisory Committee, Optometry Australia's Glaucoma Clinical Practice Guidelines and the Glaucoma Communities of Practice. Graham has lectured at both local and international conferences on the topics of glaucoma, ocular disease and advanced clinical instrumentation.
Jonathan M. Lam, MD, MBA practices in Boca Raton, Florida. He specializes in refractive cataract surgery, corneal surgery, laser vision correction, and the treatment of glaucoma.

Dr. Lam attended Tufts University in Massachusetts, and received his M.D. from the Lewis Katz School of Medicine at Temple University in Philadelphia. After completing his Ophthalmology Residency, where he also served as Chief Resident, Dr. Lam completed additional subspecialty fellowship training in Anterior Segment, Cornea, and Refractive surgery at the prestigious Harvard/Massachusetts Eye and Ear Infirmary, the #4 ranked eye hospital nationally.

Currently, Dr. Lam is an active member of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Refractive Surgery Alliance. He has published and presented his research at both national and international scientific conferences, served as a speaker on industry panels, and been an investigator on clinical trials. When he's not working, Dr. Lam enjoys playing golf and tennis, traveling, and spending time with his wife, two young boys Ethan and Gabriel, and mini-goldendoodle Ruby.
Cory J. Lappin, OD, FAAO is a native of Northeast Ohio and received his Bachelor of Science degree from Miami University, graduating Phi Beta Kappa with Honors with Distinction.

He earned his Doctor of Optometry degree from The Ohio State University College of Optometry, where he concurrently completed his Master of Science degree in Vision Science. At the college he served as Class President and was a member of Beta Sigma Kappa Honor Society.

Following graduation, Dr. Lappin continued his training by completing a residency in Ocular Disease at the renowned Cincinnati Eye Institute in Cincinnati, Ohio. Dr. Lappin has been recognized for his clinical performance, receiving the American Academy of Optometry Foundation Practice Excellence Award. He has also been actively engaged in research, being selected to take part in the NIH/NEI T35 research training program and receiving the Vincent J. Ellerbrock Memorial Award in recognition of accomplishments in vision science research.

Dr. Lappin practices at Phoenix Eye Care and the Dry Eye Center of Arizona in Phoenix, Arizona, where he treats a wide variety of ocular diseases, with a particular interest in dry eye and ocular surface disease. Additionally, he has authored numerous articles and lectures on topics related to ocular surface disease.

He is a Fellow of the American Academy of Optometry, a member of the American Optometric Association, and a member of the Board of Directors for the Arizona Optometric Association. He also volunteers with the Special Olympics Opening Eyes program. In his free time, Dr. Lappin enjoys weight lifting, trail running, and exploring the world through hiking and new culinary experiences.
Anupam Laul, OD, FAAO, DIPL ABO has been clinical faculty at SUNY Optometry since 2016. Prior to SUNY, he served as clinical faculty at Johns Hopkins, School of Medicine and the Ohio State University, College of Optometry where he was the Chief of the Ocular Disease Service. He graduated from the Michigan College of Optometry, followed by a residency in Ocular Disease at the Ophthalmic Consultants of Boston/New England College of Optometry.

He is an attending in the Primary Eye Care Service and the Glaucoma Service and also teaches ocular disease clinical procedures labs. He is the instructor of record of the Ophthalmic Lasers and In-Office Surgical Procedures course and The Role of the Optometrist in Surgical Care elective.

He is a member of the American Academy of Optometry, the American Optometric Association, the Optometric Glaucoma Society and is board certified by the American Board of Optometry. Dr. Laul is also the Chair of the Environmental Safety and Infection Control Committee and runs the Glaucoma Micro-Credential Program at the College.
Austin R. Lifferth OD, FAAO graduated from Indiana University School of Optometry in 2003 and completed a post-graduate residency in ocular disease at the Huntington, West Virginia Veterans Affairs Medical Center 2003-2004.

Since that time, he has practiced in an ophthalmology co-management center for several years at Bennett & Bloom Eye Centers, a hospital-based setting at The Villages, Florida Veterans Affairs Outpatient Clinic, and is now back home again in Indiana as a consultative optometrist with an emphasis in glaucoma management at Center for Sight in Carmel, Indiana.

Dr. Lifferth is a fellow of the American Academy of Optometry, a Glaucoma Diplomate of the American Academy of Optometry, Chair of the Glaucoma Section of the American Academy of Optometry, and is a member of the Optometric Glaucoma Society.
Nate Lighthizer, OD, FAAO is a graduate of Pacific University College of Optometry. Upon graduation, he completed a residency in Family Practice Optometry with an emphasis in Ocular Disease through Northeastern State University Oklahoma College of Optometry (NSUOCO).

Dr. Lighthizer has since joined the faculty at the Oklahoma College of Optometry and serves as the Chief of Specialty Care Clinics and the Chief of Electrodiagnostics Clinic. In 2014, he founded and now heads the Dry Eye Clinic at the College of Optometry. Also in 2014, he was named the Director of Continuing Education as well as the Assistant Dean for Clinical Care Services at the Oklahoma College of Optometry.

Starting in 2020, he was named the Associate Dean of the NSU Oklahoma College of Optometry. He is a founding member, and currently serves as President, of the Intrepid Eye Society which is a group of emerging thought leaders in optometry.

He was named a member of PCON 250 – A list of the top 250 optometrists in the country who practice progressively, provide innovative patient care, conduct optometric research or excel in academia and share what they have learned with other optometrists to advance the profession. Dr. Lighthizer lectures nationally and internationally on numerous topics, most notably advanced ophthalmic procedures, electrodiagnostics, and ocular disease.
Sarah MacIver BSc, OD, FAAO is an optometrist and associate clinical professor at the University of Waterloo School of Optometry and Vision Science. At the University of Waterloo, she is director of continuing professional development and residency supervisor for the ocular disease and glaucoma residency program.

She has a special interest in the treatment and management of chronic ocular disease, specifically glaucoma, retinal imaging and dry eye for which she has been invited to speak at various continuing education across North America.

Areas of scholarship include glaucoma, dry eye disease, retinal imaging, inter-professional collaboration with primary healthcare and optometric education. She is a member of the Optometric Glaucoma Society and program chair for the American Academy of Optometry's Glaucoma section.
Charles McBride, OD is the owner of McBride Optometrists in Beaverton, Oregon. Dr. McBride started working with contact lenses at a young age under the guidance of his father and grandfather, both optometrists.

He went on to Oregon State University and later Pacific University where he earned his doctorate.

Dr. McBride has a strong professional interest in complex contact lens fits, and is considered a leading expert in the use and fitting of scleral lenses.
Vittorio Mena, OD, MS specializes in corneal and contact lens management, serves as the sports vision director at the Optical Academy in New Jersey.

He is the Co-Clinical Director of Special Olympics Lions Club International Opening Eyes Program, servicing athletes and coaches yearly.

Dr. Mena was awarded the “Young OD of the Year 2019” by the New Jersey Society of Optometric Physicians (NJSOP) and now serves on the NJSOP board of directors.
Thuy-Lan Nguyen, OD, FAAO received her Bachelors of Science Degree from James Madison University in 1997. She graduated from Nova Southeastern University College of Optometry in 2002 with a Doctor of Optometry Degree. She completed a Residency in Primary Care with Emphasis in Cornea and Contact Lenses at NSU in 2003. Dr. Nguyen is a Fellow of the American Academy of Optometry and a Fellow of the Scleral Lens Society.

In August 2015, Dr. Nguyen joined the Nova Southeastern University Faculty on a full time basis. She is Chief of the Cornea and Contact Lens Service and currently holds the rank of Assistant Professor. She teaches in the contact lens clinic and practice management course.

Dr. Nguyen volunteers with Vision Service Plan’s mobile eye clinics and serves as VSP’s state professional representative (SPR) for South Florida. Dr. Nguyen is a member of the American Optometric Association, Florida Optometric Association, Broward County Optometric Association, American Academy of Optometry and the Scleral Lens Society.
Ada Noh, OD is a graduate of the University of Pittsburgh and Pennsylvania College of Optometry. She is an active member of the American Optometric Association, Arkansas Optometric Society, AOA Leadership institute, VC Woman Achieve, and Arkansas Women Executives.

She practiced in primary care optometry for 8 years before opening a specialty dry eye clinic. She now exclusively treats dry eye disease in Little Rock, Arkansas.
John Nolan, PhD is the Principal Investigator of the Macular Pigment Research Group (MPRG) in the Nutrition Research Centre Ireland (www.nrci.ie) in Waterford Institute of Technology, Ireland. His research group studies the role of eye nutrition for vision and prevention of blindness, and current studies are investigating the link between nutrition and brain health and function.

Dr. Nolan has secured over €5 million in research funding to date to support these studies.

He has presented at over 100 international scientific conferences and has published 89 peer-reviewed scientific papers, which have been cited 3,317 times. His H-index is 37.

He is co-editor of Carotenoids and Retinal Disease published by Taylor and Francis in 2013 & is a member of the Ocular Nutrition Society. He is currently serving his third term as Chair of the International Brain and Ocular Nutrition (BON) Conference, and is an editor of the Journal of Alzheimer’s Disease.
Carlo J. Pelino, OD, FAAO is a 1994 graduate of the Pennsylvania College of Optometry. In 1995 Dr. Pelino completed a PCO ocular disease residency at the John F. Kennedy Memorial Hospital in Philadelphia, where he concentrated in retina and neuro-ophthalmic disease. Dr. Pelino is currently a full time Assistant Professor at the Pennsylvania College of Optometry and is director of the optometric retina service at The Eye Institute.

He recently completed a one year retinal fellowship emphasizing medical and surgical treatments under the direction of vitreo-retinal surgeons at Crozier-Chester and Riddle Memorial Hospitals in suburban Philadelphia. Dr. Pelino is a fellow in the American Academy of Optometry. He regularly lectures in domestic and international programs.
Tamara Petrosyan, OD is an associate clinical professor at SUNY College of Optometry in the Primary Care, Ocular Disease, Pediatrics, and Vision Therapy departments.

Dr. Petrosyan lectures internationally and has published articles and book chapters on various topics. Dr. Petrosyan helped implement free pediatric exams for over 30,000 children through the Armenian Eyecare Project, developed over a dozen vision therapy workbooks, and helped start and previously worked with Anteo Health where she developed all of the vision therapy content.

She is the InfantSEE liaison for New Jersey, head of the clinical care committees for pediatrics and vision therapy, and previously on the board of directors for the New Jersey Society of Optometric Physicians (NJSOP). Dr. Petrosyan has received the Young Optometrist of the Year and Optometrist of the Year from NJSOP and the Young Optometrist of the Year award from the AOA.
Joseph Pizzimenti, OD, FAAO is a full-time faculty member at the University of the Incarnate Word Rosenberg School of Optometry (UIWRSO). He received his Doctor of Optometry from the Illinois College of Optometry, and completed a residency in Low Vision and Ocular Disease at the University of Houston. Dr. Pizzimenti is a Fellow of both the American Academy of Optometry (AAO) and the Optometric Retina Society (ORS), serving as ORS President from 2012-2014.

Dr. Pizzimenti’s areas of research interest include diabetes, age-related macular degeneration, vitreomacular adhesion, and low vision. His scientific articles have appeared in a host of peerreviewed journals. Dr. Pizzimenti was awarded a Fellowship by the World Council of Optometry in 2006, resulting in an appointment to teach and evaluate optometric education programs in Central Europe. He is involved in the both the didactic and clinical education at UIWRSO and the UIW Eye Institute.
Jessilin Quint OD, MBA, MS, FAAO is a Texas native and graduated from Baylor University with a Bachelor of Arts (BA) degree in Biology. She completed Master in Business Administration (MBA) and Master of Science (MS) in Biology degrees at West Texas A&M University. Dr. Quint received a Doctorate of Optometry degree (OD) from Indiana University.

After graduation, she completed a post-doctoral Residency in Ocular Disease with an emphasis on ocular emergency and trauma at the Illinois Eye Institute in Chicago, Illinois.

Dr. Quint has been an active volunteer, presenter, and author in industry publications. She is a Fellow of the American Academy of Optometry and a Board Certified Diplomate of the American Board of Optometry. Dr. Quint co-owns Smart Eye Care and Smart Eye & Med Spa in Maine. She serves as President of the Maine Optometric Association Board of Directors and is a member of the Intrepid Eye Society.
Mohammad Rafieetary, OD, FAAO is a consultative optometric physician who has been in practice at the Charles Retina Institute (CRI) since 1996. Dr. Rafieetary is a graduate of Boston University and received his Doctor of Optometry from the University of Missouri-St. Louis. He completed a residency in Primary Care Optometry and Ocular Disease at the Southern College of Optometry (SCO) and the Memphis Health Center. Upon completion of his residency in 1989, Dr. Rafieetary joined SCO's faculty and served as an Associate Professor and the Chief of Advanced Ocular Disease Service and at the Southern College of Optometry until he joined CRI.

Dr. Rafieetary has received several awards including the SCO Faculty of the Year, American Diabetic Association's National Achievement of Distinction Award, and the Tennessee Associations of Optometric Physician's Optometrist of the Year. Dr. Rafieetary has served on the board of several professional organizations such as the Church Health Center and the American Diabetes Association.

Dr. Rafieetary is a Fellow of the American Academy of Optometry and Optometric Retina Society. He is board certified by the American Board Optometry as well as the American Board of Certification in Medical Optometry. Dr. Rafieetary is licensed to practice Optometry in the states of Tennessee, Mississippi, Arkansas, Kentucky, and Texas. Dr. Rafieetary is published in numerous professional publications and lectures extensively on the subject of diseases of the eye with emphasis on conditions of the retina and vitreous.
Julie Rodman, OD, MSc, FAAO is the Chief of the Broward Eye Care Institute in Fort Lauderdale, FL. Her research interests include Optical Coherence Tomography/Angiography and Vitreoretinal Disease. Dr. Rodman has authored over thirty publications with an emphasis on retinal disease. She recently published “Optical Coherence Tomography Atlas: A Case Study Approach”, the first reference book on this topic written by an optometrist. Dr. Rodman is a member of the American Optometric Association, American Academy of Optometry, Florida Optometric Association, Optometric Retina Society and Association for Research in Vision and Ophthalmology. Dr. Rodman is a member of the Optovue Advisory Board where she serves as a lecturer and consultant. She holds her Oral Pharmaceuticals Certification and is Laser/Surgical Certified as well.

Dr. Rodman has been the recipient of numerous teaching awards, including the Golden Apple Award for Excellence in Clinical Precepting, and Preceptor of the Year. She was recognized as a Primary Care Optometry News “Top 300” Optometrists recognizing excellence in innovation and furthering of the profession. FYI: In her free time, Dr. Rodman loves spending time with her husband and two daughters….just doing anything with them!!!!
Justin Schweitzer, OD is an adjunct clinical professor at The Illinois College of Optometry and Kentucky College of Optometry. He is a national leader in glaucoma, anterior segment surgery, and anterior segment pathology who lectures to his colleagues nationwide.

Dr. Schweitzer is a member of several industry organizations, has held many leadership positions within them, is the current president of the South Dakota Optometric Society, and is involved in community eye care initiatives. He currently serves as a chief medical editor for Modern Optometry and is the Optometric Externship Director for the Illinois College of Optometry at Vance Thompson Vision.
Steve Silberberg, OD is the founder of a group practice, An Eye to the Future in Matawan, NJ, and is the Program Coordinator of CEwire.

Dr Silberberg is a frequently published author and consultant for industry. He has served as VP of the Monmouth-Ocean Counties Society of Optometric Physicians, as a member-director for IDOC alliance, an was one of the original trustees of the American Association of Doctors of Optometry (AADO). He currently serves as an administrator the Facebook group Facebook group Private Practice in Optometry, which has over 6,000 members.

Dr Silberberg graduated as departmental valedictorian from SUNY at Stony Brook before attending MIT on full scholarship in Planetary Astrophysics. He then attended SUNY College of Optometry, graduating as class valedictorian along with winning the Beta Sigma Kappa award for vision science, the Fredrick Brock award for excellence in Vision Therapy, and the Ester Werner award for academic excellence.
Steven Sorkin, OD earned his Doctor of Optometry degree from the State University of New York College of Optometry. He has received multiple clinical honors and has participated in many contact lens related studies.

He lectures extensively throughout the country and internationally on contact lenses, dry eyes, ocular allergies, ocular therapeutics and corneal disease. He has a special interest in difficult to fit contact lens patients, such as those with keratoconus and post surgical cases and manages many patients with complex anterior segment conditions.

Dr. Sorkin currently serves as President of the Essex County Optometric Society and is a member of the Board of Directors of the New Jersey Society of Optometric Physicians. He is also a Fellow of the Scleral Lens Education Society. He was named New Jersey Optometrist of the Year by NJSOP in 2018.
Jessica Steen, OD, FAAO, Dipl-ABO is an associate professor at Nova Southeastern University College of Optometry where she serves as Director of the Glaucoma Service and as an attending optometric physician at the College’s Eye Care Institute. Dr. Steen teaches the courses in glaucoma and ocular pharmacology at NSU. Dr. Steen also serves as the Primary Care with Emphasis in Ocular Disease Residency Coordinator. Dr. Steen graduated from the University of Waterloo School of Optometry and Vision Science and completed her residency in Primary Care with Emphasis in Ocular Disease at Nova Southeastern University.

Dr. Steen’s main clinical interests include glaucoma, retinal disease, neuro-ophthalmic disease with an emphasis in medical and surgical management. Dr. Steen’s research interests are centered on artificial intelligence applications in the management of glaucoma. She is a Fellow of the American Academy of Optometry, a Diplomate of the American Board of Optometry, member of the Optometric Glaucoma Society, and the Association for Research in Vision and Ophthalmology, and is Past President of the Palm Beach County Optometric Association.
Shaina Sullivan, OD is a Pacific University College of Optometry graduate who practices in Beaverton, OR in partnership with Dr. Charles McBride.

She is the Membership Director for the Oregon Optometric Physicians Association and an active advocate for optometry across the state and nation. Dr. Sullivan enjoys bowling, camping, attending local sporting events, and spending time with her husband and son.
Tracy Schroeder Swartz, OD, MS, FAAO attended Indiana University School of Optometry for her doctorate as well as a master’s degree in physiological optics. Dr. Swartz earned her Fellowship from the American Academy of Optometry and Diplomate from the American Board of Optometry, specializing in co-management and anterior segment disease. She has edited 7 textbooks, authored blogs and published numerous articles. Dr. Swartz is the Past President of the Optometric Cataract, Cornea and Refractive Surgery Society, and a member of the Alabama Optometric Association and American Optometric Association.
Jacqueline Theis OD, FAAO, FNAP is a practicing optometrist, clinical researcher, international lecturer and author. She received her doctoral and post-doctoral residency training in Neuro-Optometry and Binocular Vision disorders from the University of California at Berkeley School of Optometry.

She is a previous Assistant Clinical Professor and the Founder and Chief of the UC Berkeley Sports Vision and Concussion Clinic and currently serves as an Assistant Professor for the Uniformed Services University, School of Medicine, Department of Physical Medicine and Rehabilitation.

She has extensive clinical experience in post-traumatic brain injury and neurologic visual dysfunctions including neuropathic eye pain, neurologic dry eye, cranial nerve palsies, oculomotor dysfunction, photophobia, visual processing, and visuo-vestibular symptoms as well as neurologic dry eye.
Richard S. Witlin, MD, FACS, of the Witlin Center for Advanced Eye Care, serving East Brunswick, Toms River, and Morristown, New Jersey, is one of the pioneers in refractive surgery in the New Jersey area since 1981 when he performed the first radial keratotomy procedure in central New Jersey.

Following the FDA approval of excimer laser surgery in 1996, Dr. Witlin took up both photorefractive keratectomy (PRK) and LASIK surgery. One of the most experienced LASIK surgeons in New Jersey, Dr. Witlin has performed 6,000 LASIK procedures and 25,000 cataract procedures since 1997. The surgical results have been outstanding, with over 98% of his patients achieving 20/40 or better visual acuities.

A board-certified ophthalmic microsurgeon, Dr. Witlin received his medical degree from the Albert Einstein College of Medicine in New York City, where he graduated with honors at the top of his class and was elected to Alpha Omega Alpha, the National Medical Honor Society. He completed his internship and residency at the Albany Medical Center Hospital in Albany, New York, where he served as chief resident in ophthalmology.

Dr. Witlin is an enthusiastic refractive surgical educator, sharing his expertise with numerous professional and civic groups. He has trained and supervised many eye doctors and has lectured throughout the United States and internationally. Dr. Witlin maintains faculty appointments at several prestigious teaching hospitals, including Wills Eye Hospital in Philadelphia and the New York Eye and Ear Infirmary in New York City. In 1998, Dr. Witlin established the Witlin Center for Advanced Eye Care, dedicated to the performance of refractive eye surgery and small incision, sutureless cataract microsurgery.
Mary Beth Yackey, OD joined Cincinnati Eye Institute (CEI) in 2004. She provides patient care at the Blue Ash, Ohio and Edgewood, Kentucky offices. Dr. Yackey is a provider of Optometric Services and is a member of the Vitreoretinal team. She enjoys co-managing pre- and post-operative patients. Her practice emphasizes eye diseases such as cataract, diabetes, macula related conditions, vascular disease of the retina, and urgent eye care. As a part of her optometric training, Dr. Yackey completed four rotations with an emphasis in Ocular Disease, Specialty Contact Lens Fitting, and Pediatric and Special-Needs Populations.

Dr. Yackey recruits patients for various research projects. She is involved in teaching and educating Optometry and Ophthalmology Residents and Fellows. She is certified by the National Board of Examiners in Optometry for treatment and management of ocular disease. She currently holds active Optometry Licenses in Ohio and Kentucky.

Dr. Yackey is active in teaching optometric continuing education classes. She is also active in the community and gives numerous presentations on the importance of eye health to local elementary schools. Dr. Yackey volunteers by giving eye exams at The Cincinnati Eye Institute Foundation Roselawn Eye Clinic.

Sponsors

Check back here for the latest, exclusive show discounts that will be available in our private forum. Registered users will also receive e-mails on the latest discounts.

Platinum
OCULUS
German precision since 1895.

OCULUS has been setting milestones in the eye care industry since 1895.

We offer a wide range of products including the Pentacam®, visual field perimeters, Keratograph 5M corneal topographer, slit-lamp cameras, autorefractors, keratometers, trial frames and loupes.

OCULUS products are 100% made in Germany and fully supported in the United States.
TEC - The Eye Consortium
TEC is a philosophy, a high-level strategy that can be incorporated to accelerate any practice in any business environment with a focus on independent practices.

After years of watching profits erode and the commoditization of our dispensaries, a novel approach was imperative. Practice differentiation and the patient experience are keys to an independent and profitable practice. We did the work for you and aggregated the best-in-class, independent players in our industry, known simply as TEC - The Eye Consortium.

Be Profitable
It’s A Business. Profitability Is Not A Bad Word...We offer the best-in-class suite of solutions to help ease the pain points of running a business.

Be Differentiated
Selling better quality, individualized products within your practice will amplify patient loyalty, elevate your practice, and differentiate you from the chain groups and your biggest competitors.

Be Independent
Stop Feeding The Beast...Establishing working relationships with our vendor partners will reduce your reliance on the vertically integrated companies while keeping you authentically independent. Where you spend your money matters!
Visionix
Visionix is the global manufacturer and exclusive sales, service, and training provider of Optovue OCT, Visionix screening and refraction systems, as well as Briot and Weco lens finishing equipment in North America.

We are the pioneer in integrating core refractive, screening, and imaging technologies to address the ever-changing needs of eye care professionals. Today, we are proud to offer high-speed OCT and OCTA technology designed to facilitate the diagnosis and management of a range of ocular diseases.

Our goal is to improve access to a complete suite of advanced visual health solutions that transform the patient experience. With over 100 years of innovation, an expanded product line, as well as a new level of support, clinical education, and practice integration, we are well-positioned to help you unlock your potential.
Gold
Anagram
Anagram is building the first all-in-one medical and vision insurance billing platform for eye care providers so they can focus on running a successful business and delivering care to their patients.

Vision insurance, lab ordering, and administrative tasks can be challenging and ultimately impact the quality of care that you deliver to patients. We don't think it has to be that way.

Anagram:
• Fights for price transparency—We believe vision care should be both profitable for eye care providers and affordable for patients.
• Supports private-pay practices—We’re here for the 40,000 eye care providers across the country who struggle with vision insurance, lab ordering, and back-office tasks.
• Advances vision care—We’re building innovative technologies that let eye care providers see any patient that walks through their door.

Contact Us

We look forward to your participation! Register Here
©2025-2026 ODwire.org, a service of Proactive Optometric Physicians, LLC.